Adults using medical cannabis for sleep disorders experience little to no clinically meaningful relief in sleep quality or duration, according to a systematic review published in the Cochrane Database of Systematic Reviews. The findings challenge widespread public assumptions regarding cannabis as a proven remedy for chronic sleeplessness.
Analyzing Clinical Trials on Cannabis and Sleep
Led by Lucia B. Varela, M.D., from the Universidad Hospital Italiano de Buenos Aires in Argentina, researchers evaluated the therapeutic benefits and potential harms of medical cannabis. The team examined data from nine randomized controlled trials (RCTs) involving 537 adult participants aged 18 to 76, of whom 72.66 percent were female.
The reviewed studies primarily investigated primary insomnia, with one trial focusing on insomnia tied to coexisting medical conditions. These trials benchmarked medical cannabis against placebos, benzodiazepines, benzodiazepine receptor agonists, melatonin receptor agonists, antidepressants, and antipsychotics.
Negligible Results and Adverse Effects
When evaluated against placebos, medical cannabis failed to generate measurable improvements across key metrics, including total sleep duration and daytime functioning. While researchers observed minor indications of improved overall quality of life, they classified the certainty of this evidence as very low.
The analysis also identified a slight increase in adverse events among cannabis users, indicating potential health risks alongside unverified clinical benefits.
Current Research Deficits Prevent Clear Conclusions
Despite the lack of measurable improvement, the study's authors cautioned against dismissing the therapy entirely, pointing instead to a lack of rigorous, large-scale data.
"The main message is that the research currently available is not sufficient to reliably answer whether medical cannabis helps people with insomnia," Dr. Varela said in a statement. "This does not mean that medical cannabis is ineffective. It means that, based on the evidence we have, we cannot draw reliable conclusions about its effectiveness for insomnia in the general population."
The researchers noted that standardized trials with larger participant samples are required before medical cannabis can be clinically recommended for sleep management.
